Actively Recruiting
Screening for Neurodevelopmental Disorders in Siblings of Children With Autism Diagnosed in Tertiary Centers
Led by University Hospital, Montpellier · Updated on 2025-03-30
384
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Montpellier
Lead Sponsor
D
Direction Générale de l'Offre de Soins
Collaborating Sponsor
AI-Summary
What this Trial Is About
In this study, a selective and multi-stages screening for neurodevelopmental disorders (NDD) in siblings of children with a confirmed ASD is done. The main aims are to estimate the prevalence of NDD among siblings and to evaluate the feasibility and acceptability of a standardized screening procedure.
CONDITIONS
Official Title
Screening for Neurodevelopmental Disorders in Siblings of Children With Autism Diagnosed in Tertiary Centers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Brothers or sisters (including stepsiblings) aged between 2 and 16 years
- Living in Occitanie region
- Parents provide informed consent
- Child is affiliated with social security
- Positive screening in step 1 or parental concerns about child's development for step 2
- Parental signed informed consent for step 2
You will not qualify if you...
- Parents or child refuse to participate
- Adopted brother or sister
- Do not speak French
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chu Montpellier
Montpellier, France
Actively Recruiting
Research Team
C
Cécile MICHELON
CONTACT
C
Charlotte GERBE
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here